Earningsreport

Q2/2023 6/30/2023 EPS -0.290 ZacksConsensus -0.300 ActVsEst 0.010 - Beat

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases